![(S)-2-(4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoylamino)-penta…](https://static.cymitquimica.com/products/3D/img/FA151584.png "Click to enlarge")
(S)-2-(4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoylamino)-pentanedioicacid diethylester
CAS: 146943-43-3
Ref. 3D-FA151584
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Name:
(S)-2-(4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoylamino)-pentanedioicacid diethylester
Synonyms:
- N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester
- (s)-diethyl-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido) pentanedioate
Description:
Pemetrexed is a cancer drug that belongs to the group of diacids. It is chemically stable and has been shown to have anticancer activity in mammalian cells. Pemetrexed inhibits the growth of mesothelioma, a type of lung cancer, by binding to DNA and inhibiting DNA synthesis. The process optimization for pemetrexed was done by investigating different salt formulations, such as sodium salts or carboxylates. This drug can be used in combination with other anticancer drugs to treat other types of cancer, such as pleural mesothelioma or heptahydrate. Pemetrexed has been approved for use in Canada as an anticancer agent for the treatment of mesothelioma and lung cancers (e.g., non-small cell lung cancer).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
483.52 g/mol
Formula:
C24H29N5O6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
